INS19 CAR-T Cells for the Treatment of Relapsed or Refractory Acute B Lymphoblastic Leukemia

Conditions: Leukemia, B-cell Interventions: Biological: INS19 CAR-T Cells Sponsors: Beijing Immunochina Medical Science& Technology Co., Ltd.; Peking University People ' s Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials